| Literature DB >> 33937068 |
Xuetao Wang1, Bailin Zhang1, Qiang He1, Yilin Kong1, Zhenhui Dai1, Haoyu Meng1, Fangjun Huang2, Shengfeng Zhang1, Yuanhu Zhu1, Xiang Tan1, Xin Zhen2.
Abstract
PURPOSE: This retrospective study aimed to evaluate the dosimetric effects of a rectal insertion of Kushen Ningjiao on rectal protection using deformable dose accumulation and machine learning-based discriminative modelling.Entities:
Keywords: Kushen Ningjiao; brachytherapy; cervical cancer; dose accumulation; rectum
Year: 2021 PMID: 33937068 PMCID: PMC8085420 DOI: 10.3389/fonc.2021.657208
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Figure 1(A) Kushen Ningjiao (20 g, 5 g × 4); (B) pre- and (C) post-Kushen Ningjiao.
Figure 2Flattening the 3D rectum surface dose to obtain 2D RSDM. The rectum was subdivided into anterior and posterior parts.
Extracted dosimetric features.
| DVPs (50) | D0.1cc–D5.0cc |
|---|---|
|
| Global ( |
|
| Area_1Gy–Area_30Gy, Rel_area_1Gy–Rel_area_30Gy, Ecc_1Gy–Ecc_30Gy, Maj_1Gy–Maj_30Gy, Min_1Gy–Min_30Gy, Per_1Gy–Per_30Gy, Cen2But_1Gy–Cen2But_30Gy, Cen2Lft_1Gy–Cen2Lft_30Gy, Cen2Rgt_1Gy–Cen2Rgt_30Gy |
Figure 3DGPs extracted from the 2D-RSDM.
Feature selection strategies and classifiers for discrimination modeling.
| Feature selection strategies*1 ( | CIFE ( |
| Classifier models*2 ( | Logistic regression, SVM, naïve Bayes, KNN, decision tree, bagging, random forest, AdaBoosting |
The feature selection strategies and classifier models were implemented with the open-source machine learning toolkits *1scikit-feature (29) and *2scikit-learn (39), respectively.
Figure 4Example 2D-RSDM of a patient with (A) pre-KN and (B) post-KN.
Rectum geometric changes and dosimetric comparisons.
| Pre- | Post- |
| |||
|---|---|---|---|---|---|
| Distance to CTV (mm) | Anterior | 24.7 (23.2–26.2) | 23.4 (22.3–24.6) | <0.001 | |
| Posterior | 47.1 (45.2–49.5) | 48.8 (47.1–51.8) | <0.001 | ||
| Volume of rectal wall (cm3) | 15.0 (13.1–17.8) | 18.0 (16.4–20.3) | <0.001 | ||
| Distance in rectal wall (mm) | AP1 | 23.3 ± 4.2 | 26.5 ± 3.6 | <0.001 | |
| Ambilateral | 22.7 ± 4.9 | 28.1 ± 4.1 | <0.001 | ||
| Dx-cc (Gy) | D0.1cc | Anterior | 24.4 (22.9–25.9) | 22.3 (20.6–24.4) | <0.001 |
| Posterior | 11.7 ± 2.2 | 9.6 ± 2.3 | <0.001 | ||
| D1cc | Anterior | 12.7 ± 3.0 | 12.3 ± 2.9 | =0.298 | |
| Posterior | 7.5 ± 1.6 | 4.8 ± 1.7 | <0.001 | ||
| D2cc | Anterior | 7.1 ± 3.1 | 7.4 ± 2.7 | =0.275 | |
| Posterior | 4.5 ± 2.0 | 2.0 ± 1.1 | <0.001 | ||
| D5cc | Anterior | 1.8 (1.5–2.0) | 1.8 (1.6–2.0) | =0.930 | |
| Posterior | 1.2 (1.0–1.4) | 0.9 (0.8–1.0) | <0.001 | ||
Paired-sample Student t test.
Wilcoxon signed-rank test.
AP1, Distance between the anterior and posterior rectal walls.
Figure 5Number of times (%) the dosimetric features were selected as top 20 features in the fivefold cross-validation of all the discriminative models with AUCs >0.80. The most frequent 10 features are underlined. Number of times (%) being selected as the Top-20 features in the (A) whole, (B) anterior and (C) posterior rectal surface dose.
Top 10 most frequently selected features.
| Feature category | Top-ranked features (ranking no.) | Pre- | Post- |
| |
|---|---|---|---|---|---|
| Whole | DGPs ( | Rel_area_6Gy (1st) | 55.4 ( ± 12.5) | 50.5 ( ± 11.3) | <0.001 |
| Rel_area_9Gy (3rd) | 37.4 ( ± 10.4) | 31.1 ( ± 8.2) | <0.001 | ||
| Per_2Gy (6th) | 496.9 ( ± 86.4) | 527.0 ( ± 70.0) | <0.001 | ||
| Area_2Gy (7th) | 9,057.5 ( ± 2051.6) | 10,456.6 ( ± 2062.3) | <0.001 | ||
| Per_1Gy (9th) | 463.7 (424.5–512.2) | 516.9 (477.1–545.7) | <0.001 | ||
| Min_2Gy (9th) | 96.1 (84.5–106.7) | 97.6 (86.9–114.4) | =0.273 | ||
| DVPs ( | D0.1cc (4th) | 24.4 (22.9–25.9) | 22.3 (20.6–24.4) | <0.001 | |
| D0.2cc (7th) | 22.1 (20.6–23.8) | 20.3 (18.3–22.8) | <0.001 | ||
| Textures ( | GLSZM_HGZE (2nd) | 12,187.2 ± 3610.9 | 10,567.9 ± 3067.7 | <0.001 | |
| NGTDM_Busyness (4th) | 7.7 (6.0,9.5) (×10-3) | 7.5 (6.5,9.5) (×10-3) | =0.947 | ||
| Anterior | DGPs ( | Cen2Lft_29Gy (1st) | 3.1 (0.0–8.2) | 0 (0.0–4.5) | =0.008 |
| Maj_3Gy (2nd) | 104.5 (89.2–120.9) | 104.0 (91.7–117.5) | =0.897 | ||
| Cen2Rgt_1Gy (2nd) | 67.8 (57.5–82.9) | 78.3 (73.3–90.5) | <0.001 | ||
| Rel_area_6Gy (2nd) | 36.4 ( ± 5.7) | 36.3 ( ± 5.0) | =0.837 | ||
| Per_12Gy (2nd) | 237.4 (212.9–284.8) | 230.0 (199.8–264.2) | =0.115 | ||
| Cen2Lft_30Gy (2nd) | 0.4 (0.0–6.7) | 0.0 (0.0–1.8) | =0.029 | ||
| Textures ( | NGTDM_Busyness (1st) | 2.9 (2.4,3.8) (×10-3) | 3.0 (2.6,3.7) (×10-3) | =0.864 | |
| NGTDM_Contrast (1st) | 0.2 ( ± 0.08) | 0.2 ( ± 0.08) | =0.713 | ||
| NGTDM_Coarseness (1st) | 2.1 ( ± 0.6) (×10-2) | 1.9 ( ± 0.4) (×10-2) | =0.001 | ||
| NGTDM_Complexity (1st) | 41128.2 ( ± 11549.0) | 41182.5 ( ± 11141.7) | =0.969 | ||
| Posterior | DGPs ( | Maj_25Gy (5th) | 104.6 (90.2–122.4) | 104.2 (92.3–120.2) | =0.952 |
| DVPs ( | D2.5cc (1st) | 2.7 (1.9–4.6) | 1.2 (1.0–1.6) | <0.001 | |
| D2.6cc (2nd) | 2.6 (1.8–4.4) | 1.2 (1.0–1.6) | <0.001 | ||
| D2.2cc (4th) | 3.8 (2.3–5.5) | 1.4 (1.1–1.8) | <0.001 | ||
| D2.3cc (6th) | 3.6 (2.3–5.2) | 1.3 (1.1–1.8) | <0.001 | ||
| D2.1cc (7th) | 4.2 ( ± 2.0) | 1.8 ( ± 1.0) | <0.001 | ||
| D2.0cc (7th) | 4.5 ( ± 2.0) | 2.0 ( ± 1.1) | <0.001 | ||
| D1.0cc (9th) | 7.5 ( ± 1.6) | 4.8 ( ± 1.7) | <0.001 | ||
| D1.5cc (10th) | 5.8 ( ± 1.8) | 3.0 ( ± 1.5) | <0.001 | ||
| Textures ( | NGTDM_Strength (3rd) | 488.2 ( ± 136.5) | 456.9 ( ± 132.3) | =0.098 |
Paired-sample Student t test.
Wilcoxon signed-rank test.
Figure 6Projection of the top 10 features [(A) whole; (B) anterior; (C) posterior] of the pre-KN (green) and post-KN (orange) groups onto the two-dimensional scatter plot.
Rectal toxicity grading of the eight patients who presented with symptoms.
| Patient # | Symptoms | Grade |
|---|---|---|
| 1st | Mucous bloody stool and rectal and anal ulcer | 2 |
| 2nd | Diarrhea, abdominal pain, bloody mucous stool, and tenesmus | 2 |
| 3rd | Bloody stool, lower gastrointestinal bleeding, and proctorrhagia | 3 |
| 4th | Yellow sodden feces two to four times per day and tenesmus | 1 |
| 5th | More times of stools (>5 times) | 2 |
| 6th | Anal bearing-down with vague pain, tenesmus, more times of stool, and colonic polyps | 2 |
| 7th | Anal bearing-down and hematochezia | 2 |
| 8th | More times of stools (<5 times) and colorectal inflammation | 1 |